| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Other Original Articles |
Mothers and Babies Research Centre (V.E.M., T.Z., R.S., W.B.G., V.L.C.), University of Newcastle; and Department of Respiratory and Sleep Medicine (P.G.G.), John Hunter Hospital, Newcastle, New South Wales 2310, Australia
Address all correspondence and requests for reprints to: Dr.Vicki Clifton, Mothers and Babies Research Centre, Endocrine Unit, John Hunter Hospital, Locked Bag 1, Hunter Region Mail Center, Newcastle, New South Wales, 2310, Australia. E-mail: . vclifton{at}mail.newcastle.edu.au
Abstract
Pregnancies complicated by asthma are associated with an increased risk of low birth weight. Currently, the mechanisms causing this outcome are unknown. To investigate whether impaired placental function may be a determinant, we measured placental 11ß-hydroxysteroid dehydrogenase type 2 (11ß-HSD2) activity, protein and mRNA, placental CRH mRNA, fetal cortisol, and fetal estriol concentrations at delivery.
Asthmatic subjects were classified according to inhaled glucocorticoid intake during pregnancy and compared with a control nonasthmatic group. There was a 25% reduction in neonatal birth weight centile in asthmatic women who did not use inhaled glucocorticoid treatment. This was accompanied by significantly reduced placental 11ß-HSD2 activity, significantly increased fetal cortisol, and a trend toward increased placental CRH mRNA and reduced fetal estriol concentrations. The use of inhaled glucocorticoids for treatment was associated with birth weight centile, 11ß-HSD2 activity, CRH mRNA, fetal cortisol, and estriol concentrations similar to control levels. There was a significant inverse correlation between fetal cortisol and fetal estriol concentrations across all groups.
These studies demonstrate that inhaled glucocorticoid intake for the treatment of asthma is associated with improved placental function and fetal outcome, suggesting that inflammatory factors associated with asthma may be detrimental to fetal growth and development in these pregnancies.
This article has been cited by other articles:
![]() |
A. Sharma, H. Guan, and K. Yang The p38 Mitogen-Activated Protein Kinase Regulates 11{beta}-Hydroxysteroid Dehydrogenase Type 2 (11{beta}-HSD2) Expression in Human Trophoblast Cells through Modulation of 11{beta}-HSD2 Messenger Ribonucleic Acid Stability Endocrinology, September 1, 2009; 150(9): 4278 - 4286. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Stark, I. M. R. Wright, and V. L. Clifton Sex-specific alterations in placental 11{beta}-hydroxysteroid dehydrogenase 2 activity and early postnatal clinical course following antenatal betamethasone Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2009; 297(2): R510 - R514. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Wyrwoll, J. R. Seckl, and M. C. Holmes Altered Placental Function of 11{beta}-Hydroxysteroid Dehydrogenase 2 Knockout Mice Endocrinology, March 1, 2009; 150(3): 1287 - 1293. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Scott, N. A. Hodyl, V. E. Murphy, A. Osei-Kumah, H. Wyper, D. M. Hodgson, R. Smith, and V. L. Clifton Placental Cytokine Expression Covaries with Maternal Asthma Severity and Fetal Sex J. Immunol., February 1, 2009; 182(3): 1411 - 1420. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Michael and A. T. Papageorghiou Potential significance of physiological and pharmacological glucocorticoids in early pregnancy Hum. Reprod. Update, September 1, 2008; 14(5): 497 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Holmes, C. T. Abrahamsen, K. L. French, J. M. Paterson, J. J. Mullins, and J. R. Seckl The mother or the fetus? 11beta-hydroxysteroid dehydrogenase type 2 null mice provide evidence for direct fetal programming of behavior by endogenous glucocorticoids. J. Neurosci., April 5, 2006; 26(14): 3840 - 3844. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus Endocr. Rev., April 1, 2006; 27(2): 141 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yang, L. Julan, F. Rubio, A. Sharma, and H. Guan Cadmium reduces 11{beta}-hydroxysteroid dehydrogenase type 2 activity and expression in human placental trophoblast cells Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E135 - E142. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Murphy, P. G. Gibson, P. I. Talbot, C. G. Kessell, and V. L. Clifton Asthma self-management skills and the use of asthma education during pregnancy Eur. Respir. J., September 1, 2005; 26(3): 435 - 441. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Murphy, R. F. Johnson, Y.-C. Wang, K. Akinsanya, P. G. Gibson, R. Smith, and V. L. Clifton The Effect of Maternal Asthma on Placental and Cord Blood Protein Profiles Reproductive Sciences, July 1, 2005; 12(5): 349 - 355. [Abstract] [PDF] |
||||
![]() |
V. E. Murphy, P. G. Gibson, R. Smith, and V. L. Clifton Asthma during pregnancy: mechanisms and treatment implications Eur. Respir. J., April 1, 2005; 25(4): 731 - 750. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Murphy, P. G. Gibson, W. B. Giles, T. Zakar, R. Smith, A. M. Bisits, C. G. Kessell, and V. L. Clifton Maternal Asthma Is Associated with Reduced Female Fetal Growth Am. J. Respir. Crit. Care Med., December 1, 2003; 168(11): 1317 - 1323. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |